171 related articles for article (PubMed ID: 10337992)
21. [Rearrangement of the RET gene in papillary thyroid carcinoma].
Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064
[TBL] [Abstract][Full Text] [Related]
22. The physical map of the human RET proto-oncogene.
Pasini B; Hofstra RM; Yin L; Bocciardi R; Santamaria G; Grootscholten PM; Ceccherini I; Patrone G; Priolo M; Buys CH
Oncogene; 1995 Nov; 11(9):1737-43. PubMed ID: 7478601
[TBL] [Abstract][Full Text] [Related]
23. A novel multicolor hybridization scheme applied to localization of a transcribed sequence (D10S170/H4) and deletion mapping in the thyroid cancer cell line TPC-1.
Jossart GH; O'Brien B; Cheng JF; Tong Q; Jhiang SM; Duh Q; Clark OH; Weier HU
Cytogenet Cell Genet; 1996; 75(4):254-7. PubMed ID: 9067436
[TBL] [Abstract][Full Text] [Related]
24. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM
Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704
[TBL] [Abstract][Full Text] [Related]
25. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
[TBL] [Abstract][Full Text] [Related]
26. The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2.
Minoletti F; Butti MG; Coronelli S; Miozzo M; Sozzi G; Pilotti S; Tunnacliffe A; Pierotti MA; Bongarzone I
Genes Chromosomes Cancer; 1994 Sep; 11(1):51-7. PubMed ID: 7529046
[TBL] [Abstract][Full Text] [Related]
27. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
[TBL] [Abstract][Full Text] [Related]
28. [Radiation-induced thyroid carcinomas in children: high prevalence of RET rearrangement].
Rabes HM; Klugbauer S
Verh Dtsch Ges Pathol; 1997; 81():139-44. PubMed ID: 9474864
[TBL] [Abstract][Full Text] [Related]
29. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
[TBL] [Abstract][Full Text] [Related]
30. Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).
Kulkarni S; Heath C; Parker S; Chase A; Iqbal S; Pocock CF; Kaeda J; Cwynarski K; Goldman JM; Cross NC
Cancer Res; 2000 Jul; 60(13):3592-8. PubMed ID: 10910073
[TBL] [Abstract][Full Text] [Related]
31. RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma.
Corvi R; Berger N; Balczon R; Romeo G
Oncogene; 2000 Aug; 19(37):4236-42. PubMed ID: 10980597
[TBL] [Abstract][Full Text] [Related]
32. The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications.
Komminoth P
Virchows Arch; 1997 Jul; 431(1):1-9. PubMed ID: 9247627
[TBL] [Abstract][Full Text] [Related]
33. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A
Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903
[TBL] [Abstract][Full Text] [Related]
34. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.
Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT
Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154
[TBL] [Abstract][Full Text] [Related]
35. Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC.
Sozzi G; Pierotti MA; Miozzo M; Donghi R; Radice P; De Benedetti V; Grieco M; Santoro M; Fusco A; Vecchio G
Oncogene; 1991 Feb; 6(2):339-42. PubMed ID: 2000227
[TBL] [Abstract][Full Text] [Related]
36. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
37. Novel germline RET mutation segregating with papillary thyroid carcinomas.
Rey JM; Brouillet JP; Fonteneau-Allaire J; Boneu A; Bastié D; Maudelonde T; Pujol P
Genes Chromosomes Cancer; 2001 Dec; 32(4):390-1. PubMed ID: 11746981
[TBL] [Abstract][Full Text] [Related]
38. H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization.
Celetti A; Cerrato A; Merolla F; Vitagliano D; Vecchio G; Grieco M
Oncogene; 2004 Jan; 23(1):109-21. PubMed ID: 14712216
[TBL] [Abstract][Full Text] [Related]
39. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas.
Fluge O; Haugen DR; Akslen LA; Marstad A; Santoro M; Fusco A; Varhaug JE; Lillehaug JR
Oncogene; 2001 Feb; 20(7):885-92. PubMed ID: 11314023
[TBL] [Abstract][Full Text] [Related]
40. Development of a single-step duplex RT-PCR detecting different forms of ret activation, and identification of the third form of in vivo ret activation in human papillary thyroid carcinoma.
Jhiang SM; Smanik PA; Mazzaferri EL
Cancer Lett; 1994 Apr; 78(1-3):69-76. PubMed ID: 8180971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]